Skip to main content
Top
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

How can insulin initiation delivery in a dual-sector health system be optimised? A qualitative study on healthcare professionals’ views

Authors: Ping Yein Lee, Yew Kong Lee, Chirk Jenn Ng

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

The prevalence of type 2 diabetes is increasing at an alarming rate in developing countries. However, glycaemia control remains suboptimal and insulin use is low. One important barrier is the lack of an efficient and effective insulin initiation delivery approach. This study aimed to document the strategies used and proposed by healthcare professionals to improve insulin initiation in the Malaysian dual-sector (public–private) health system.

Methods

In depth interviews and focus group discussions were conducted in Klang Valley and Seremban, Malaysia in 2010–11. Healthcare professionals consisting of general practitioners (n = 11), medical officers (n = 8), diabetes educators (n = 3), government policy makers (n = 4), family medicine specialists (n = 10) and endocrinologists (n = 2) were interviewed. We used a topic guide to facilitate the interviews, which were audio recorded, transcribed verbatim and analysed using a thematic approach.

Results

Three main themes emerged from the interviews. Firstly, there was a lack of collaboration between the private and public sectors in diabetes care. The general practitioners in the private sector proposed an integrated system for them to refer patients to the public health services for insulin initiation programmes. There could be shared care between the two sectors and this would reduce the disproportionately heavy workload at the public sector. Secondly, besides the support from the government health authority, the healthcare professionals wanted greater involvement of non-government organisations, media and pharmaceutical industry in facilitating insulin initiation in both the public and private sectors. The support included: training of healthcare professionals; developing and disseminating patient education materials; service provision by diabetes education teams; organising programmes for patients’ peer group sessions; increasing awareness and demystifying insulin via public campaigns; and subsidising glucose monitoring equipment. Finally, the healthcare professionals proposed the establishment of multidisciplinary teams as a strategy to increase the rate of insulin initiation. Having team members from different ethnic backgrounds would help to overcome language and cultural differences when communicating with patients.

Conclusion

The challenges faced by a dual-sector health system in delivering insulin initiation may be addressed by greater collaborations between the private and public sectors and governmental and non-government organisations, and among different healthcare professionals.
Literature
1.
go back to reference Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998, 352 (9131): 837-853. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998, 352 (9131): 837-853.
2.
go back to reference DeWitt DE, Hirsch IB: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003, 289 (17): 2254-2264. 10.1001/jama.289.17.2254.CrossRefPubMed DeWitt DE, Hirsch IB: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003, 289 (17): 2254-2264. 10.1001/jama.289.17.2254.CrossRefPubMed
3.
go back to reference Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, Rawdaree P, Plengvidhya N, Leelawatana R, Bunnag P, Pratipanawatr T, Krittiyawong S, Suwanwalaikorn S, et al: Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage. J Med Assoc Thai. 2006, 89 (Suppl 1): S66-71.PubMed Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, Rawdaree P, Plengvidhya N, Leelawatana R, Bunnag P, Pratipanawatr T, Krittiyawong S, Suwanwalaikorn S, et al: Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage. J Med Assoc Thai. 2006, 89 (Suppl 1): S66-71.PubMed
4.
go back to reference Liebl A, Mata M, Eschwege E: Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia. 2002, 45 (7): S23-28.CrossRefPubMed Liebl A, Mata M, Eschwege E: Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia. 2002, 45 (7): S23-28.CrossRefPubMed
5.
go back to reference McFarlane SI, Jacober SJ, Winer N, Kaur J, Castro JP, Wui MA, Gliwa A, Von Gizycki H, Sowers JR: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care. 2002, 25 (4): 718-723. 10.2337/diacare.25.4.718.CrossRefPubMed McFarlane SI, Jacober SJ, Winer N, Kaur J, Castro JP, Wui MA, Gliwa A, Von Gizycki H, Sowers JR: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care. 2002, 25 (4): 718-723. 10.2337/diacare.25.4.718.CrossRefPubMed
6.
go back to reference Fox KM, Gerber Pharmd RA, Bolinder B, Chen J, Kumar S: Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002. Clin Ther. 2006, 28 (3): 388-395. 10.1016/j.clinthera.2006.03.005.CrossRefPubMed Fox KM, Gerber Pharmd RA, Bolinder B, Chen J, Kumar S: Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002. Clin Ther. 2006, 28 (3): 388-395. 10.1016/j.clinthera.2006.03.005.CrossRefPubMed
7.
go back to reference Eliasson B, Cederholm J, Nilsson P, Gudbjornsdottir S: The gap between guidelines and reality: type 2 diabetes in a National Diabetes Register 1996–2003. Diabet Med. 2005, 22 (10): 1420-1426. 10.1111/j.1464-5491.2005.01648.x.CrossRefPubMed Eliasson B, Cederholm J, Nilsson P, Gudbjornsdottir S: The gap between guidelines and reality: type 2 diabetes in a National Diabetes Register 1996–2003. Diabet Med. 2005, 22 (10): 1420-1426. 10.1111/j.1464-5491.2005.01648.x.CrossRefPubMed
8.
go back to reference Koro CE, Bowlin SJ, Bourgeois N, Fedder DO: Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004, 27 (1): 17-20. 10.2337/diacare.27.1.17.CrossRefPubMed Koro CE, Bowlin SJ, Bourgeois N, Fedder DO: Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004, 27 (1): 17-20. 10.2337/diacare.27.1.17.CrossRefPubMed
11.
go back to reference Ismail M, Chew BH, Lee PY, Cheong AT, Shariff GS, Haniff J, Syed Abdul Rahman SA, Taher SW, Ahmad Z: Control and treatment profiles of 70,889 adult type 2 diabetes mellitus patients in Malaysia - a cross sectional survey in 2009. Int J Collaborative Res Internal Med Pu Health. 2011, 3: 98-113. Ismail M, Chew BH, Lee PY, Cheong AT, Shariff GS, Haniff J, Syed Abdul Rahman SA, Taher SW, Ahmad Z: Control and treatment profiles of 70,889 adult type 2 diabetes mellitus patients in Malaysia - a cross sectional survey in 2009. Int J Collaborative Res Internal Med Pu Health. 2011, 3: 98-113.
12.
go back to reference Donnan PT, Steinke DT, Newton RW, Morris AD: Changes in treatment after the start of oral hypoglycaemic therapy in Type 2 diabetes: a population-based study. Diabet Med. 2002, 19 (7): 606-610. 10.1046/j.1464-5491.2002.00743.x.CrossRefPubMed Donnan PT, Steinke DT, Newton RW, Morris AD: Changes in treatment after the start of oral hypoglycaemic therapy in Type 2 diabetes: a population-based study. Diabet Med. 2002, 19 (7): 606-610. 10.1046/j.1464-5491.2002.00743.x.CrossRefPubMed
13.
go back to reference Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, Chandran LR, Tee GH, Jamaiyah H, Isa MR, Zanariah H, Fatanah I, Ahmad Faudzi Y: Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. Med J Malaysia. 2010, 65 (3): 180-186.PubMed Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, Chandran LR, Tee GH, Jamaiyah H, Isa MR, Zanariah H, Fatanah I, Ahmad Faudzi Y: Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. Med J Malaysia. 2010, 65 (3): 180-186.PubMed
14.
go back to reference Haque M, Emerson SH, Dennison CR, Navsa M, Levitt NS: Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. S Afr Med J. 2005, 95 (10): 798-802.PubMed Haque M, Emerson SH, Dennison CR, Navsa M, Levitt NS: Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. S Afr Med J. 2005, 95 (10): 798-802.PubMed
15.
go back to reference Pope C, Mays N: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995, 311 (6996): 42-45. 10.1136/bmj.311.6996.42.CrossRefPubMedPubMedCentral Pope C, Mays N: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995, 311 (6996): 42-45. 10.1136/bmj.311.6996.42.CrossRefPubMedPubMedCentral
16.
go back to reference Bogdan R, Taylor SJ: Introduction to qualitative research methods. 1975, New York: John Wiley Bogdan R, Taylor SJ: Introduction to qualitative research methods. 1975, New York: John Wiley
17.
go back to reference Patton MQ: Qualitative evaluation methods. 1980, Newbury Park, CA: Sage Patton MQ: Qualitative evaluation methods. 1980, Newbury Park, CA: Sage
19.
go back to reference Lee YK, Lee PY, Ng CJ: A qualitative study on healthcare professionals’ perceived barriers to insulin initiation in a multi-ethnic population. BMC Fam Pract. 2012, 13 (1): 28-10.1186/1471-2296-13-28.CrossRefPubMedPubMedCentral Lee YK, Lee PY, Ng CJ: A qualitative study on healthcare professionals’ perceived barriers to insulin initiation in a multi-ethnic population. BMC Fam Pract. 2012, 13 (1): 28-10.1186/1471-2296-13-28.CrossRefPubMedPubMedCentral
20.
go back to reference Planning and Development Division: Health facts 2009: Information and Documentation System Unit. 2010, Putrajaya: Ministry of Health Malaysia Planning and Development Division: Health facts 2009: Information and Documentation System Unit. 2010, Putrajaya: Ministry of Health Malaysia
21.
go back to reference Family Health Development Division: Family Health Development Division statistic 2009. 2009, Putrajaya: Ministry of Health Malaysia Family Health Development Division: Family Health Development Division statistic 2009. 2009, Putrajaya: Ministry of Health Malaysia
22.
go back to reference National Institute of Health: National Health Care Establishment and Workforce Statistics 2008–2009. 2010, Putrajaya: Clinical Research Centre, National Institute of Health, Ministry of Health Malaysia National Institute of Health: National Health Care Establishment and Workforce Statistics 2008–2009. 2010, Putrajaya: Clinical Research Centre, National Institute of Health, Ministry of Health Malaysia
24.
go back to reference Bazzoli GJ, Stein R, Alexander JA, Conrad DA, Sofaer S, Shortell SM: Public-private collaboration in health and human service delivery: evidence from community partnerships. Milbank Q. 1997, 75 (4): 533-561. 10.1111/1468-0009.00068.CrossRefPubMedPubMedCentral Bazzoli GJ, Stein R, Alexander JA, Conrad DA, Sofaer S, Shortell SM: Public-private collaboration in health and human service delivery: evidence from community partnerships. Milbank Q. 1997, 75 (4): 533-561. 10.1111/1468-0009.00068.CrossRefPubMedPubMedCentral
25.
go back to reference The Economic Planning Unit: 9th Malaysian Plan – 2006–2010. 2006, Putrajaya: Prime Minister’s Department of Malaysia The Economic Planning Unit: 9th Malaysian Plan – 2006–2010. 2006, Putrajaya: Prime Minister’s Department of Malaysia
27.
go back to reference Safurah J: In 15th Malaysian Family Medicine Scientific Conference: 23–26 June 2011; Seremban, Negeri Sembilan, Malaysia. One care for one Malaysia: Why and How. Abstract of Plenary lecture. 2011 Safurah J: In 15th Malaysian Family Medicine Scientific Conference: 23–26 June 2011; Seremban, Negeri Sembilan, Malaysia. One care for one Malaysia: Why and How. Abstract of Plenary lecture. 2011
28.
go back to reference Angell M: The truth about the drug companies: how they deceive us and what to do about it. 2004, New York: Random House Angell M: The truth about the drug companies: how they deceive us and what to do about it. 2004, New York: Random House
29.
go back to reference Moynihan R, Cassells A: Selling sickness: how the drug companies are turning us all into patients. 2005, Sydney: Allen & Unwin Moynihan R, Cassells A: Selling sickness: how the drug companies are turning us all into patients. 2005, Sydney: Allen & Unwin
30.
go back to reference Jl C: The constant gardener. 2001, New York: Simon and Schuster Jl C: The constant gardener. 2001, New York: Simon and Schuster
31.
go back to reference Wazana A: Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA. 2000, 283 (3): 373-380. 10.1001/jama.283.3.373.CrossRefPubMed Wazana A: Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA. 2000, 283 (3): 373-380. 10.1001/jama.283.3.373.CrossRefPubMed
32.
go back to reference Chren MM: Interactions between physicians and drug company representatives. Am J Med. 1999, 107 (2): 182-183.CrossRefPubMed Chren MM: Interactions between physicians and drug company representatives. Am J Med. 1999, 107 (2): 182-183.CrossRefPubMed
33.
go back to reference Shipp DH, Mallarkey G: Liaison between public hospital staff and the pharmaceutical industry: guidance from the NSW Therapeutic Advisory Group. Med J Aust. 2009, 190 (8): 406-407.PubMed Shipp DH, Mallarkey G: Liaison between public hospital staff and the pharmaceutical industry: guidance from the NSW Therapeutic Advisory Group. Med J Aust. 2009, 190 (8): 406-407.PubMed
34.
go back to reference White AR: The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: a successful collaborative model. J Antimicrob Chemother. 2008, 62 (Suppl 2): ii3-14.PubMed White AR: The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: a successful collaborative model. J Antimicrob Chemother. 2008, 62 (Suppl 2): ii3-14.PubMed
35.
go back to reference Komesaroff PA: Relationships between health professionals and industry: maintaining a delicate balance. Aust Prescriber. 2007, 30: 150-153.CrossRef Komesaroff PA: Relationships between health professionals and industry: maintaining a delicate balance. Aust Prescriber. 2007, 30: 150-153.CrossRef
36.
go back to reference Komesaroff PA, Bach MA, Danoff A, Grumbach MM, Kaplan S, Lakoski JM, Leitman D, Mellon S, Underwood LE, Leupen S: The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interests, October 2003. Endocrinology. 2004, 145 (6): 3032-3041.CrossRefPubMed Komesaroff PA, Bach MA, Danoff A, Grumbach MM, Kaplan S, Lakoski JM, Leitman D, Mellon S, Underwood LE, Leupen S: The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interests, October 2003. Endocrinology. 2004, 145 (6): 3032-3041.CrossRefPubMed
38.
go back to reference BickestaffeI R, Brock P, Husson J-M, Rubin I, Bragman K, Paterson K, Sommerville A: Ethics and pharmaceutical medicine – the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. BickestaffeI R, Brock P, Husson J-M, Rubin I, Bragman K, Paterson K, Sommerville A: Ethics and pharmaceutical medicine – the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK.
39.
go back to reference Haines IE, Olver IN: Are self-regulation and declaration of conflict of interest still the benchmark for relationships between physicians and industry?. Med J Aust. 2008, 189 (5): 263-266.PubMed Haines IE, Olver IN: Are self-regulation and declaration of conflict of interest still the benchmark for relationships between physicians and industry?. Med J Aust. 2008, 189 (5): 263-266.PubMed
40.
go back to reference Green S: Ethics and the pharmaceutical industry. Australas Psychiatry. 2008, 16 (3): 158-165. 10.1080/10398560701842595.CrossRefPubMed Green S: Ethics and the pharmaceutical industry. Australas Psychiatry. 2008, 16 (3): 158-165. 10.1080/10398560701842595.CrossRefPubMed
41.
go back to reference Danika VH, Jones SC, Iverson DC: Consumer perceptions of sponsors of disease awareness advertising. Health Education. 2011, 111 (1): 5-19.CrossRef Danika VH, Jones SC, Iverson DC: Consumer perceptions of sponsors of disease awareness advertising. Health Education. 2011, 111 (1): 5-19.CrossRef
44.
go back to reference Del Prato S, Felton AM, Munro N, Nesto R, Zimmet P, Zinman B: Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract. 2005, 59 (11): 1345-1355. 10.1111/j.1742-1241.2005.00674.x.CrossRefPubMed Del Prato S, Felton AM, Munro N, Nesto R, Zimmet P, Zinman B: Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract. 2005, 59 (11): 1345-1355. 10.1111/j.1742-1241.2005.00674.x.CrossRefPubMed
45.
go back to reference Codispoti C, Douglas MR, McCallister T, Zuniga A: The use of a multidisciplinary team care approach to improve glycemic control and quality of life by the prevention of complications among diabetic patients. J Okla State Med Assoc. 2004, 97 (5): 201-204.PubMed Codispoti C, Douglas MR, McCallister T, Zuniga A: The use of a multidisciplinary team care approach to improve glycemic control and quality of life by the prevention of complications among diabetic patients. J Okla State Med Assoc. 2004, 97 (5): 201-204.PubMed
46.
go back to reference Gagliardino JJ, Etchegoyen G: A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care. 2001, 24 (6): 1001-1007. 10.2337/diacare.24.6.1001.CrossRefPubMed Gagliardino JJ, Etchegoyen G: A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care. 2001, 24 (6): 1001-1007. 10.2337/diacare.24.6.1001.CrossRefPubMed
47.
go back to reference Caballero AE: Building cultural bridges: understanding ethnicity to improve acceptance of insulin therapy in patients with type 2 diabetes. Ethn Dis. 2006, 16 (2): 559-568.PubMed Caballero AE: Building cultural bridges: understanding ethnicity to improve acceptance of insulin therapy in patients with type 2 diabetes. Ethn Dis. 2006, 16 (2): 559-568.PubMed
Metadata
Title
How can insulin initiation delivery in a dual-sector health system be optimised? A qualitative study on healthcare professionals’ views
Authors
Ping Yein Lee
Yew Kong Lee
Chirk Jenn Ng
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-313

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue